The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,998,672 in first-year total cost, median $999,800.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-Q (J1)]4
Most frequent institutions
- FOX CHASE CHEMICAL DIVERSITY CENTER, INC1
- JBS SCIENCE, INC.1
- ONCOCEUTICS, INC.1
- PRIVO TECHNOLOGIES, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Development of a urine test for the early detection of liver cancer2R44CA165312-05 | LIN, SELENA | JBS SCIENCE, INC., PA | $1,000,000 | ZCA1 |
| 2018 | Riluzole Prodrugs for Melanoma and ALS2R44CA156781-04A1 | REITZ, ALLEN BERNARD | FOX CHASE CHEMICAL DIVERSITY CENTER, INC, PA | $1,000,000 | ZCA1 |
| 2018 | Adaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma2R44CA192427-04 | OSTER, WOLFGANG | ONCOCEUTICS, INC., PA | $999,600 | ZCA1 |
| 2018 | Supportive Clinical Trial Tasks for Nanotechnology-Based Treatment of Oral Cancer2R44CA192875-04 | GOLDBERG, MANIJEH NKEITH, DONNA | PRIVO TECHNOLOGIES, LLC, MA | $999,072 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.